🇺🇸 FDA

Intelligence · Patent portfolio

Structure Therapeutics Patents

Full USPTO pharma patent portfolio for Structure Therapeutics — grant dates, expiration, and drug cross-links.

Patents
93
Expiring ≤24m
1

Quick answer

Structure Therapeutics has 93 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 1 expire within 24 months — use filters for patent-cliff planning.

Page 2 of 2

  1. US 9782387

    Compositions and methods for treating hematological malignancies

    Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 9777050

    Peptides and compositions for prevention of cell adhesion and methods of using same

    Expires Mon Sep 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 9771567

    Klotho variant polypeptides

    Expires Mon Sep 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 9770469

    Methods of reprogramming renal cells

    Expires Mon Sep 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 9758831

    Methods of predicting clinical course and treating multiple sclerosis

    Expires Mon Sep 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 9737571

    Compositions of aquatic origin for prevention of cell adhesion and methods of using same

    Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 9732124

    Peptides and compositions for prevention of cell adhesion and methods of using same

    Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 9688697

    RNA polymerase I inhibitors and uses thereof

    Expires Mon Jun 22 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 9663569

    Use of blocking agents of bone morphogenic protein (BMP) signalling for the treatment of neuroinflammatory and neurodegenerative diseases

    Expires Mon May 25 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 9663790

    Adipocyte-specific constructs and methods for inhibiting platelet-type 12 lipoxygenase expression

    Expires Mon May 25 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 9610331

    Methods for hematopoietic precursor mobilization

    Expires Mon Mar 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 9492480

    Iron oxide nanoparticles for use in treating non-infectious inflammatory disorders

    Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 9481894

    Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues

    Expires Mon Oct 27 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 9434741

    Thieno[2,3-d]pyrimidine derivatives, preparation method and use thereof

    Expires Mon Sep 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 9394569

    Methods and kits for early detection of cancer or predisposition thereto

    Expires Mon Jul 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 9261507

    Anti CEACAM1 antibodies and methods of using same

    Expires Mon Feb 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 9238838

    Microrna patterns for the diagnosis, prognosis and treatment of melanoma

    Expires Mon Jan 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 9193718

    Quinazoline derivative and application thereof

    Expires Mon Nov 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 9180152

    Method for treating psoriasis

    Expires Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 9067989

    Eotaxin-2 (CCL24) inhibitors in inflammatory, autoimmune, and cardiovascular disorders

    Expires Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 9066907

    Methods for treating burns-related systemic inflammatory response syndrome

    Expires Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 9045550

    Peptides and compositions for prevention of cell adhesion and methods of using same

    Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 9029318

    Peptides and compositions for prevention of cell adhesion and methods of using same

    Expires Mon May 07 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 8980549

    MicroRNA patterns for the diagnosis, prognosis and treatment of melanoma

    Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 8969292

    High affinity leptins and leptin antagonists

    Expires Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 8962561

    Compositions comprising PEDF and uses of same in the treatment and prevention of ovary-related syndromes

    Expires Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 8961993

    Method of treating retinitis pigmentosa

    Expires Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8912142

    Method of regulating proliferation and differentiation of keratinocyes

    Expires Mon Dec 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 8828722

    Isolated populations of renal stem cells and methods of isolating and using same

    Expires Mon Sep 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 8785373

    Agents capable of downregulating an MSF-A-dependent HIF-1alpha and use thereof in cancer treatment

    Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 8741315

    Methods of treating tumors in immune-privileged sites

    Expires Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 8614301

    Methods of treating cancer using anti CD24 antibodies

    Expires Mon Dec 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 8597655

    Recombinant fusion protein and polynucleotide construct for immunotoxin production

    Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 8598322

    Anti CEACAM1 antibodies and methods of using same

    Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 8552147

    Peptides and compositions for prevention of cell adhesion and methods of using same

    Expires Mon Oct 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 8541185

    Method of predicting responsiveness to autologous adoptive cell transfer therapy

    Expires Mon Sep 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 8529907

    Methods of treating ophthalmic disorders

    Expires Mon Sep 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 8391959

    Composition for improving efficiency of drug delivery

    Expires Mon Feb 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 8343549

    Therapeutic uses of Dunaliella powder

    Expires Mon Dec 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 8338624

    Isoflavone derivatives and uses thereof

    Expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 8242076

    Polypeptides, matrices, hydrogels and methods of using same for tissue regeneration and repair

    Expires Mon Aug 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 7994306

    Methods of treating cancer using siRNA molecules directed against CD24

    Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 7985428

    Method and composition for modulation of systemic inflammatory responses syndrome (SIRS)

    Expires Mon Jul 21 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 7763255

    Therapeutic uses of Dunaliella powder

    Expires Mon Jul 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 7264813

    Therapeutic uses of Dunaliella powder

    Expires Mon Aug 30 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Structure Therapeutics have?

93 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Structure Therapeutics patents expire?

1 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.